In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1933 News Items found
Colorectal Surgeon Dr. Julio Garcia-Aguilar seen smiling in office.
New Colorectal Cancer Treatments at MSK Aim To Reduce Deaths and Preserve Quality of Life

Learn about the latest treatments for colon and rectal (colorectal) cancer at Memorial Sloan Kettering Cancer Center.
Christina Leslie
Decoding the Cell: A Conversation with Dr. Christina Leslie

Dr. Christina Leslie’s work sits at the crossroads of two technological revolutions: single-cell genomics and artificial intelligence. We sat down with Dr. Leslie to discuss the promise — and limitations — of this technological frontier, and what it means for cancer research.
Four people treated for rectal cancer in a clinical trial at MSK are seen outdoors with the trial’s two principal investigators.
FDA Approves Immunotherapy-Only Approach for Some Rectal Cancers: What Patients Need To Know

The FDA approved a treatment for rectal cancer tumors with a specific genetic signature that uses only the immunotherapy Jemperli, allowing some patients to be successfully treated without surgery, radiation, or chemotherapy.
Beth and Mark Ryzyk stand on a long bridge
Promising New Results for Melanoma mRNA Vaccine

New results from a cancer vaccine designed to prevent melanoma from returning after surgery showed positive results, according to a phase 3 clinical trial.
Memorial Sloan Kettering medical oncologist Eileen O'Reilly
Vaccine Targeting KRAS in Pancreatic Cancer Shows Promise

Read about a therapeutic vaccine that could potentially prevent certain pancreatic cancers from returning.
Detail of a researcher working in an MSK lab
MSK Research Highlights, October 22, 2026

New MSK research shows how genes activate across vast distances inside a cell; identifies a new form of cell death that could open new opportunities for cancer therapy; uncovers hidden genetics involved in autism; develops an AI tool that can predict a cell’s fate and help change it; and finds STAT3 acts as an inflammation-sensing switch in natural killer cells.
Dr. June Lee and Dr. Genovefa Papanicolaou
FDA Approves Pritelivir To Treat Herpes Infections in Immunocompromised Patients

The FDA has approved pritelivir for treating herpes simplex virus in immunocompromised patients, including those who are undergoing cancer treatment.
Adrianna Gildner, thyroid cancer patient, wearing orange Fred’s Team shirt, smiling and giving thumbs up in Italy.
Article
Targeted Therapy for Thyroid Cancer Helps Save a Young Voice

Learn how a young woman with thyroid cancer avoided extensive surgery due to MSK's treatment expertise.
A gloved hand holds a petri dish
Gerstner Sloan Kettering Graduate Students Receive 2026-2027 Fellowships

A number of Gerstner Sloan Kettering students working in labs across MSK have received prestigious fellowships granted by external agencies and benefactors of the school.
Michelle Villagomez, a patient treated at MSK for metaplastic breast cancer
How MSK’s Expertise Treated a Rare Metaplastic Breast Cancer

Patients like Michelle benefit from the specialized skills of experts in MSK’s Rare Breast Cancer Program.